ProImmune unveils ProVE SL monomers to boost T cell research

New self-loading reagents offer unmatched flexibility for immunologists

ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science company says the innovation will offer researchers greater flexibility, speed and coverage across more than 50 HLA alleles.

The monomers are supplied as robust, empty, biotinylated MHC Class I molecules, covering HLA-A, HLA-B, HLA-C, non-canonical alleles and mouse H-2.

Researchers can load their own peptides and combine…